Literature DB >> 31971149

Intraocular Infiltration.

Koju Kamoi1, Kyoko Ohno-Matsui1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31971149      PMCID: PMC6947777          DOI: 10.4269/ajtmh.19-0539

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
A 58-year-old man presented with general malaise and showed positive results for human T-cell leukemia virus type 1 (HTLV-1) infection. As blood tests revealed abnormal leukocytes and flower cells, smoldering-type adult T-cell leukemia/lymphoma (ATL) was diagnosed. After 7 years, the condition changed to acute-type ATL. Blood tests identified an increase in CD4 from 995 cells/µL to 1,256 cells/µL and monoclonal integration of HTLV-1 provirus into tumor cells. Treatment was started with chemotherapy and allogeneic bone marrow transplantation. During follow-up, he was referred to the ophthalmology department after experiencing sudden visual loss in the right eye. Slit-lamp examination revealed cellular infiltration in the anterior chamber and vitreous humor. Fundus examination showed yellowish-white infiltrative foci associated with protrusions in the retina. Optical coherence tomography revealed massive solid infiltrative foci below the retinal pigment epithelium (Figure 1). As differential diagnoses for co-infections of the eye, our recent nationwide survey revealed cytomegalovirus (CMV) as a major cause of opportunistic infection in the eye of ATL patients, followed by herpesvirus and toxoplasma.[1] In addition, co-infections of the eye in immunocompetent patients are not frequently confirmed using serologic diagnostic methods.[2] Multiplex polymerase chain reaction (PCR) and broad-range PCR of a sample of aqueous humor, therefore, ruled out viral (human simplex virus-1 and 2, varicella zoster virus, Epstein–Barr virus, CMV, and human herpesvirus 6–8), toxoplasma, tuberculosis, syphilis, and bacterial and fungal infections, ruling out opportunistic infection and allowing the diagnosis of intraocular leukemic cell infiltration.[3] Elevated lesions on the retina improved after two vitreous injections of 400 μg/0.1 mL of methotrexate and subsided with five sessions of 2-Gy radiotherapy. Corresponding to this combination therapy, retinal lesions gradually resolved within 6 months (Figure 2).
Figure 1.

Yellowish-white infiltrative foci associated with protrusions in the retina (upper figure). Optical coherence tomography reveals massive solid infiltrative foci below the retinal pigment epithelium (lower figure). White line represents scan line. This figure appears in color at

Figure 2.

Infiltration is reduced 6 months after vitreous injection of methotrexate concomitant with radiotherapy. This figure appears in color at

Yellowish-white infiltrative foci associated with protrusions in the retina (upper figure). Optical coherence tomography reveals massive solid infiltrative foci below the retinal pigment epithelium (lower figure). White line represents scan line. This figure appears in color at Infiltration is reduced 6 months after vitreous injection of methotrexate concomitant with radiotherapy. This figure appears in color at Globally, HTLV-1 infection is now the focus of attention, since the discovery that more than 40% of adults from Aboriginal communities in central Australia are infected with HTLV-1.[4] This infection causes ATL and also visual impairment by ATL-related ocular manifestations.[5] As HTLV-1–associated ATL is a neoplasia characterized by massive invasion of leukemic cells into various organs, physicians should keep in mind that intraocular infiltration is the most frequent manifestation observed among HTLV-1–associated ATL patients.[1]
  5 in total

1.  Time to eradicate HTLV-1: an open letter to WHO.

Authors:  Fabiola Martin; Yutaka Tagaya; Robert Gallo
Journal:  Lancet       Date:  2018-05-10       Impact factor: 79.321

Review 2.  A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases.

Authors:  Manabu Mochizuki; Sunao Sugita; Koju Kamoi; Hiroshi Takase
Journal:  Jpn J Ophthalmol       Date:  2016-10-27       Impact factor: 2.447

Review 3.  HTLV infection and the eye.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Curr Opin Ophthalmol       Date:  2012-11       Impact factor: 3.761

4.  Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey.

Authors:  Koju Kamoi; Akihiko Okayama; Shuji Izumo; Isao Hamaguchi; Kaoru Uchimaru; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Front Microbiol       Date:  2019-01-08       Impact factor: 5.640

5.  Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin.

Authors:  Alejandra de-la-Torre; Juanita Valdés-Camacho; Clara López de Mesa; Andrés Uauy-Nazal; Juan David Zuluaga; Lina María Ramírez-Páez; Felipe Durán; Elizabeth Torres-Morales; Jessica Triviño; Mateo Murillo; Alba Cristina Peñaranda; Juan Carlos Sepúlveda-Arias; Jorge Enrique Gómez-Marín
Journal:  BMC Infect Dis       Date:  2019-01-25       Impact factor: 3.090

  5 in total
  1 in total

Review 1.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.